Cancer Chemoprevention: Classic and Epigenetic Mechanisms Inhibiting Tumorigenesis. What Have We Learned So Far?

Cancers derive from step by step processes which are differentiated by the progressively accumulated mutations. For some tumors there is a clear progressive advancement from benign lesions to malignancy and for these, preventive screening programs exist. In such cases having those benign lesions are...

Descripción completa

Detalles Bibliográficos
Autores principales: de Melo, Fabiana Henriques Machado, Oliveira, Julia Salles, Sartorelli, Viviani Olivastro Bressani, Montor, Wagner Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309127/
https://www.ncbi.nlm.nih.gov/pubmed/30627525
http://dx.doi.org/10.3389/fonc.2018.00644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309127/
https://www.ncbi.nlm.nih.gov/pubmed/30627525
http://dx.doi.org/10.3389/fonc.2018.00644

Ejemplares similares